Repligen Corp. (RGEN)
Repligen Market Cap : 7.638B for Feb. 20, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Abbott Laboratories | 195.12B |
| Accuray, Inc. | 60.67M |
| Alphatec Holdings, Inc. | 1.933B |
| Boston Scientific Corp. | 110.60B |
| Plus Therapeutics, Inc. | 37.79M |
Market Cap Related Metrics
| PE Ratio | 5258.91 |
| PS Ratio | 10.81 |
| Price to Book Value | 3.666 |
| Price to Free Cash Flow | 73.97 |
| Price | 135.68 |
| Earnings Yield | 0.02% |
| Operating PE Ratio | 163.84 |
| Normalized PE Ratio | 225.94 |